Chennai: Dr M Balasubramanyam, a senior scientist and Dean of Research at Madras Diabetes Research Foundation (MDRF), Chennai, has been elected as a Fellow of the National Academy of Medical Sciences (NAMS), India.
NAMS is a unique academy that fosters and utilises academic excellence as its resource to meet medical and social goals. Every year, NAMS recognises outstanding achievements of Indian scientists in the field of medicine and allied sciences and very limited fellowships are conferred to the most distinguished scientists through a peer-reviewed process and voting by the fellows.
This year (2019), Dr Balasubramanyam has been elected as a Fellow of the Academy in the recognition of his achievements in the discipline of molecular medicine with special reference to studying the new-biology insights of the aetiology and pathogenesis of diabetes and its complications.
Dr Balasubramanyam’s research team at MDRF is addressing certain unique questions: What’s the clinical utility of assessing cellular stress signalling in diabetes; Is type 2 diabetes in Indians linked to accelerated aging; What are the early biomarkers to predict the development of kidney or eye disease in diabetic patients; How to predict risk of diabetes in pregnant women; What’s the gut microbial connection to diabetes; Is environmental contaminants like bisphenol-A (BPA) – a cause for concern in diabetes; How to scientifically evaluate the therapeutic merits of herbal medicine as well as probiotics; and What is the science behind yoga/exercise benefits – to name a few.
Outcomes from these clinically relevant research programmes are expected to be a component of clinical decision-making in the futuristic personalised or precision medicine.
Dr Balasubramanyam is also serving as a Science Communicator, mentoring young students to take up science careers, frequently speaking to them on: Borderless Biology, Converging Science, and The Need for Science Entrepreneurship.